Phase I Study of SHR7390 in Patients With Advanced Solid Tumors
Condition(s):Solid TumorLast Updated:January 15, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):Solid TumorLast Updated:January 15, 2019Unknown status
Condition(s):Solid TumorLast Updated:February 20, 2020Completed
Condition(s):Solid TumorLast Updated:April 12, 2023Completed
Condition(s):Advanced Solid TumorLast Updated:August 4, 2023Not yet recruiting
Condition(s):Advanced/Metastatic Solid TumorsLast Updated:February 24, 2023Recruiting
Condition(s):Metastatic Solid TumorLast Updated:January 23, 2024Recruiting
Condition(s):HER-2 Positive Advanced Solid TumorsLast Updated:February 1, 2024Recruiting
Condition(s):Advanced Solid TumorLast Updated:August 3, 2018Unknown status
Condition(s):Advanced Solid TumorLast Updated:June 9, 2023Recruiting
Condition(s):Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or LymphomaLast Updated:May 6, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.